Events2018-03-29T14:41:36+00:00

Events

“Better Science, Better Health” hosts a series of international conferences to outline research and innovation in adaptive clinical pathways and patient data usage.

Forthcoming Event

Webinar: Equity and Outcomes, Ensuring Fair Access to Healthcare

28 September 2021, 4pm UK

Life expectancy is generally on the increase, including healthy life expectancy. New treatments that have greatly improved the chance of survival following the diagnosis of life-threatening diseases.

However, comparisons of survival rates reveal striking differences among countries for cancers, cardiovascular disorders and other serious non-communicable and communicable diseases, even between countries with a similar GDP. What are the reasons for these differences and, more importantly, what are the best ways to address them? The aim of the session is to raise awareness among health policy makers, clinical and biotechnology, health professionals, academics and interested public and patients about gaps and needs for equity in health outcomes and fair access to healthcare.

REGISTER

Recent Events

WEBINAR: GetReal – Identifying the Operational challenges of Performing RWE Research (WP3)

October 6, 2016

WP 3 has two main goals. Identify operational challenges when implementing RWE research to investigate the effectiveness of medicines, earlier in the medicine development process. Second, to estimate the impact of these challenges on the ability to generate the RWE originally aimed for and the feasibility of the research and provide practical solutions to help address them. This webinar will update you on these goals.

Archive

Webinar: RWE, CAR-T and Cancer – New Methods for Comparative Effectiveness

With the increasing use of new regulatory tools, like the FDA’s breakthrough therapy designation, there are increasing demands for European health technology assessors (HTAs) to make an accurate assessment of the long-term value and performance of CAR-T therapies from smaller datasets and shorter outcomes. This webinar will highlight our recent publication in the BMJ, sponsored by ZIN, which showcases a novel approach to harnessing RWE and develops a longitudinal data set that can be used for effectiveness measures, even in orphan conditions. As well, we will kickoff our new research project in Diffuse large B-cell lymphoma (DLBCL) and describe how we will leverage our methodology to measure the effectiveness of the various options for treatment, both in emerging CAR-T treatments, as well as existing chemotherapy regimes and bone-marrow transplants.

More Info

Tomorrow’s Cures: Impacts of the International Pricing Index

Hosted by GIPC and Vital Transformation Thursday, July 18, 2019 – 4:00 – 5:00 PM Capitol Hill Visitor’s Center (Room 209-08) First St. NE, Washington, DC 20515 We invite you to join us for a discussion on how the International Pricing Index (IPI) penalizes innovation by targeting companies with the most advanced, newest products. Join GIPC and Vital Transformation to discuss the impacts of IPI on patients, outcomes, and innovation.

WATCH VIDEO

Investing in EU Biotech IP – What Works?

4 December 2018 - 2.00-3.00pm CET, 8.00-9.00am ET In this webinar we: • Highlight the results of the research • Expand on the datapackage used • Discuss the gap between EU and US IP productivity in healthcare • Address the need for IP in the global biotech sector

Download Video & Slides

Supporting IP in Europe

Vital Transformation leads a new consortia investigating the relationship between public funding and private investment into new innovative therapies and the supporting system of IP. This project will develop original research investigating the success factors that create successful EU biotech companies and communicate the importance of IP in creating an ecosystem where investors are willing to lose everything 92% of the time, in order to fund the 8% of medical breakthroughs that succeed.

More Info

DIA Global 2018: Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies


24th June 2018, Boston, USA
Duane Schulthess, Managing Director of Vital Transformation, and Luca Pani, former Director General of the Italian Medicine's Agency and currently a Faculty Member at the University of Miami, will run a 3 hour and 15 minute Short Course outlining how best to harness RWE to better understand the price, value, and impact of next generation therapies.

DIA Bioventure Day 2017 – Crown Plaza Glasgow, UK

March 28th, 2017

DIA is excited to convene its 1st BioVenture Day, in a unique format with participation of a very broad set of senior Health Care stakeholders.You will be able to explore whether the current BioVenture paradigm is delivering return for patients, investors, and the Health Care system.

EMIF: E-managing the Future of Health Data

March 16th-17th, Budapest

Harnessing electronic health records and real world evidence to create new therapies more efficiently is quickly becoming a reality. How do we maximize the benefits offered by harnessing available health data while solving issues around its reuse and work with regulators to provide the right evidence?.

Supported by:

Go to Top